Close Menu

NEW YORK (360Dx) – Clearbridge Health Limited said today that it has entered into an exclusive partnership with Hunan, China's Agen Medicine Laboratory Technology Company, under which it will provide the firm with its ClearCell FX1 System for circulating tumor cell enrichment, offer training and assistance in Agen's development of laboratory developed tests, and then market those tests in China.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.